Clinical Trials Logo

Pelvic Inflammatory Disease clinical trials

View clinical trials related to Pelvic Inflammatory Disease.

Filter by:

NCT ID: NCT05970783 Recruiting - Chronic Pelvic Pain Clinical Trials

A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Start date: November 8, 2022
Phase: Phase 3
Study type: Interventional

The objective of this phase III trial to evaluate the efficacy and safety of Jincaopian Tablets in the treatment of subjects with chronic pelvic pain after pelvic inflammatory disease

NCT ID: NCT05648747 Recruiting - Clinical trials for Pelvic Inflammatory Disease

Pelvic Inflammatory Disease in COVID-19 Era

Start date: January 1, 2023
Phase:
Study type: Observational

The goal of this retrospective cohort study is to to scrutinize the impact of coronavirus disease 2019 (COVID-19) on incidence, demography and patient characteristics in Pelvic Inflammatory Disease comparing with the equal time duration, before and after lockdown was initiated in the country. The main aim of this study was to compare the demographic and clinical parameters between two cohorts before the onset of lockdown and within the pandemic.

NCT ID: NCT05460546 Completed - Chronic Pelvic Pain Clinical Trials

The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Start date: January 19, 2021
Phase: Phase 2
Study type: Interventional

This phase II trial attempts to evaluate the efficacy and safety of Jincaopian Tablets in the treatment of subjects with chronic pelvic pain after pelvic inflammatory disease.

NCT ID: NCT05408624 Recruiting - Abscess Clinical Trials

Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses

AmbATO
Start date: July 15, 2022
Phase:
Study type: Observational

Pelvic inflammatory diseases (PID) require antibiotic treatment. Among PID, the investigators distinguish: pelvi-peritonitis and pelvic collections such as Douglas abscess and/or tubo-ovarian abscess (TOA). Recent recommendations published in December 2018 by the National College of French Gynecologists and Obstetricians (CNGOF) suggest that it is preferable to drain TOA when their size is greater than 3-4 cm. Ultrasound-guided transvaginal drainage is recommended as first-line treatment because of its ease of performance and its effectiveness. In the literature, many authors have demonstrated the feasibility and efficacy of transvaginal drainage associated with antibiotics in the treatment of TOA. Since ultrasound-guided transvaginal drainage is a less invasive alternative therapeutic procedure than laparoscopy for the drainage of TOA, it would be compatible with outpatient management. This mode of management can be carried out in a dedicated outpatient or functional exploration room with the help of a nurse but without an anesthetic team present. This gesture is simple and short-lived. In addition, the antibiotics used have pharmacological properties allowing oral intake from their initiation. The investigators have proposed a new service protocol to treat TOA in this outpatient mode. The investigators therefore wish to analyze this new protocol from these three angles: 1/ the feasibility of this care, 2/ the quality of life of the patients through questionnaires given throughout the care and 3/ an evaluation of the 'efficiency.

NCT ID: NCT05040334 Recruiting - Clinical trials for Antibiotics Causing Adverse Effects in Therapeutic Use

Role of Prophylactic Antibiotics in Preventing Pelvic Infection After Surgical Evacuation

Start date: January 1, 2021
Phase: Phase 4
Study type: Interventional

To determine the role of antibiotic prophylaxis in the surgical management of miscarriage.

NCT ID: NCT04723069 Completed - Clinical trials for Pelvic Inflammatory Disease

Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases

Start date: September 21, 2021
Phase: Phase 2
Study type: Interventional

Randomized, double blind and positive-controlled clinical trial to assess the efficacy and safety of Fuke Qianjin Capsule compared to Doxycycline Hyclate Tablet in patients with mild to medium PID and its sequalae.

NCT ID: NCT04567771 Recruiting - Endometriosis Clinical Trials

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Start date: December 4, 2020
Phase: N/A
Study type: Interventional

This early phase I trial compares the side effects between patients treated with proton radiation therapy versus intensity modulated radiation therapy after surgery for the treatment of endometrial or cervical cancer. Radiation therapy uses high energy protons or x-rays to kill tumor cells and shrink tumors. Using quality of life questionnaires and adverse event assessments may help doctors learn whether proton radiation therapy is associated with lower acute gastrointestinal toxicities at the end of treatment compared to intensity modulated radiation therapy in patients with endometrial or cervical cancer.

NCT ID: NCT04234945 Recruiting - Infertility, Female Clinical Trials

Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure Morbidity

Start date: January 13, 2020
Phase: N/A
Study type: Interventional

The study will be a parallel randomised trial. There are two groups. The first group will be given prophylactic antibiotics before a procedure (hysterosalpingography) and the second group will be given a placebo(multivitamin). Outcomes will then be assessed.

NCT ID: NCT04179149 Completed - Quality of Life Clinical Trials

Enriched Environments in Endometriosis

Start date: September 13, 2019
Phase: N/A
Study type: Interventional

The investigators propose to conduct a randomized behavioral trial that will produce a clinically useful multi-level integrative medicine model to be used in stress- and inflammation-related disorders that can easily be implemented with current pharmacological interventions to alleviate pain and improve QoL.

NCT ID: NCT04104542 Completed - Depression Clinical Trials

MOCHI: An RCT of Mindfulness as Treatment for Chronic Pelvic Pain in AD Women

AD
Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Subject Population: Active duty (AD) women with chronic pelvic pain (CPP) have different demands and stressors placed on them compared with their civilian counterparts. Due to a decrease in functionality from pain, not addressing these women's untreated CPP could be detrimental in readiness missions. With limited studies on AD women with CPP or sufficient treatments available, this study seeks to compare the effects on pain, depression, and inflammation in the mindfulness-based stress reduction (MBSR) group with a self-paced Healthy Lifestyle (HL) education control. Research Design: This randomized controlled trial will compare depression, pain, and biomarkers known for inflammation and pain in AD women with CPP pre-post an 8-week MBSR online intervention (n=55) with a self-directed Healthy Lifestyle control (n=55). Instruments: All participants will complete a demographic worksheet, Five Facets of Mindfulness Questionnaire (FFQ), a brief pain inventory (BPI), and a Patient Health Questionnaire (PHQ-9) pre-post intervention (MBSR or HL). Procedure: Participants will have 8-weeks of online training with voice-over slides in RedCap. The primary investigator will contact participants weekly for both groups and review diaries to help monitor fidelity and guide progress. Blood will be drawn for biomarkers for inflammation and pain and questionnaires will be completed pre-post intervention.